Food & Health
Law & Insurance
Nano & Biomaterials
Markets & Trends
Welcome to the
European Life Science Journal for international business
Get inspired by the entrepreneurs leading the way of tomorrow´s life science businesses !
Norway Fresh money to target Axl
Bergenbio AS has raised NOK75m (€8.87m) from investors both old and new through a private placement. The Norwegian oncology specialist wants to use the funds for the development of their cancer therapeutics portfolio.Part of the proceeds will go towards the completion of the phase Ib clinical studies for Bergenbios lead drug candidate BGB324. The first-in-class selective Axl kinase inhibitor h...
EU okays next MS blockbuster
Biogen Idec has gained EU regulatory support for its oral multiple sclerosis drug Tecfidera.Following a positive opinion from the European Medicines Agency’s CHMP, dimethyl fumarate (Tecfidera) wa...
New Findings Demonstrate Technological Advances for Extending Serum Half-Life of Drugs Bound to Albumin
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has announced new data on extending the serum half-life of albumin in vivo.This compelling data set, recently presented...
TCGA Bladder Cancer Study Reveals Potential Drug Targets, Similarities to Several Cancers
Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified new potential therapeutic targets for a major form of bladder cancer, including important genes and pathways that...
Panama okays GM mosquito release
Panama has approved field release experiments with Oxitecs sterile mosquitoes as a novel tool to combat the spread of the dengue carrier.Following an 25% increase in dengue fever cases last year c...
AstraZeneca closes India R&D unit
The drug maker is to close its Avishkar R&D centre in Bangalore, India, and move parts of its research to Great Britain.The move that will impact 168 employees and early-stage research on tub...
New mechanism for genome unpacking in stem cells identified
Scientists at Karolinska Institutet and Gurdon Institute in Cambridge, United Kingdom have identified a novel mechanism allowing pluripotent stem cells to maintain their genome in an unpacked stat...
Genomic Analysis Reveals 2 Separate Molecular Profiles of Invasive Bladder Cancer
BUFFALO, NY — In the first whole-genome analysis conducted through the Roswell Park Cancer Institute (RPCI) Center for Personalized Medicine, researchers report that invasive bladder cancers demon...
Genmab raises €133m
Danish antibody developer Genmab A/S raised €133m after placing 4,600,000 shares at DKK 217 per share.The company said it will use the money from its private placement to push clinical developme...
Pancreatic cancer biomarker
Danish researchers have identified diagnostic microRNA panels in whole blood that can discriminate patients with and without pancreatic cancer.Although the findings reported in the current issue o...